# Safety and Practicalities of Bispecific T‐Cell Engager Administration in a District General Hospital Setting

**Authors:** Benjamin Lau, Simran Gabrie, Prudence Hobbs, Joel Newman, Abier Elzein, Nigel Sargant, Anna Cowley, Albena Nikolova, Cliona Flanagan, Lorraine Burt, Maggie Saddleton, Clare Evans, Theresa Street, Hiba Mahbak, Arturo Lazaro, Richard Grace, John R. Jones

PMC · DOI: 10.1002/jha2.70074 · EJHaem · 2025-06-06

## Full-text entities

- **Genes:** CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}
- **Diseases:** PD (MESH:D010300), Myeloma (MESH:D009101), BiTEs (MESH:D001733), cancer (MESH:D009369), fever (MESH:D005334), died (MESH:D003643), infection (MESH:D007239), ICANS (MESH:C000722498), immune (MESH:D007154), CRS (MESH:D000080424)
- **Chemicals:** Tocilizumab (MESH:C502936), pomalidomide (MESH:C467566), Penta (MESH:C064764), bortezomib (MESH:D000069286), carfilzomib (MESH:C524865), BiTE (-), lenalidomide (MESH:D000077269)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12141921/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12141921/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12141921/full.md

---
Source: https://tomesphere.com/paper/PMC12141921